Introduction: Who Should Undergo Diagnostics and When

Anyone who suddenly experiences blurry vision, vision loss, or notices dark spots floating in their field of vision should seek diagnostic testing as soon as possible. Retinal vein occlusion, often shortened to RVO, typically affects one eye and can develop without warning over a period of hours or days. The symptoms may appear suddenly or gradually worsen, making it difficult to predict when the condition will strike.^[1]

Some people may not notice any symptoms at all until complications develop. In these cases, the blockage is only discovered during a routine eye examination when an eye doctor examines the back of the eye. This is why regular eye exams become increasingly important as you age, particularly if you are over 40 years old. The condition most commonly affects people in their 50s and 60s, though it can occur in younger individuals as well.^[1]

If you have certain medical conditions that increase your risk, you should be especially vigilant about eye changes and schedule regular eye examinations. People with high blood pressure, diabetes, atherosclerosis (hardening of the arteries), or glaucoma (high pressure in the eye) are at higher risk of developing retinal vein occlusion. Additionally, if you’ve already experienced this condition in one eye, you face an increased risk of developing it in your other eye, making ongoing monitoring essential.^[1][5]

Age itself is a major risk factor. Being over 40 increases your chances of developing RVO, with the majority of cases occurring in people aged 60 and above. The risk increases with age because blood vessels can become stiffer and more prone to blockages over time. Smoking also raises your risk, as it affects blood vessel health throughout the body, including those in the eyes.^[6]

Diagnostic Methods: Identifying and Distinguishing the Condition

Diagnosing retinal vein occlusion involves several specialized tests that allow eye doctors to see inside your eye and assess the health of your retina and its blood vessels. The primary diagnostic tool is a comprehensive dilated eye exam, which is simple and painless. During this examination, your doctor places special drops in your eyes to widen, or dilate, your pupils. This allows them to look through the enlarged opening and examine the retina at the back of your eye in detail.^[12]

When the pupil is dilated, the eye doctor can see whether there are signs of a blocked vein, such as bleeding in the retina, swelling, or changes in the appearance of the blood vessels. They look for specific patterns that indicate whether the main vein is blocked (central retinal vein occlusion) or one of the smaller branch veins (branch retinal vein occlusion). The dilated exam also helps identify any complications that may have developed as a result of the blockage.^[5]

Beyond the basic dilated eye examination, doctors use several advanced imaging and testing techniques to get a more complete picture of what’s happening inside your eye. Fluorescein angiography is a common diagnostic test where your doctor injects a special fluorescent dye into a vein in your arm. This dye travels through your bloodstream and eventually reaches the blood vessels in your retina. As the dye flows through these vessels, a special camera takes detailed photographs. These images show exactly where blood is flowing normally and where it might be blocked or leaking. This test is particularly helpful in determining whether the blockage is severe and whether abnormal new blood vessels have started to grow.^[5][12]

Another important diagnostic tool is optical coherence tomography, or OCT. This is a non-invasive imaging test that uses light waves to take cross-sectional pictures of your retina. Think of it as similar to an ultrasound, but using light instead of sound waves. The OCT shows the different layers of the retina in remarkable detail, allowing your doctor to see if fluid has accumulated in the retina, particularly in the macula (the central part of the retina responsible for sharp, detailed vision). This test helps doctors measure the amount of swelling, a condition called macular edema, which is one of the main complications of retinal vein occlusion. The OCT can also be repeated during treatment to monitor whether therapies are working to reduce the swelling.^[12]

Doctors also measure intraocular pressure, which is the pressure inside your eye. This is important because retinal vein occlusion can lead to the growth of abnormal blood vessels, which in turn can cause a dangerous increase in eye pressure and lead to a type of glaucoma. The pressure measurement is typically done using a device called a tonometer, which gently touches the surface of your eye after numbing drops are applied, or uses a puff of air to measure pressure without touching your eye at all.^[5]

A visual acuity test is performed to determine how well you can see. This is the familiar test where you read letters on a chart, starting with large letters at the top and progressing to smaller ones. The results help your doctor understand how much your vision has been affected by the blockage and serve as a baseline for tracking whether your vision improves, stays stable, or worsens over time with treatment.^[5]

Visual field examination, also called perimetry, tests your side (peripheral) vision. During this test, you focus on a central point while lights appear in different areas of your peripheral vision. You indicate when you see each light. This helps identify blind spots or areas where vision has been lost due to the blockage. It’s particularly useful for understanding the extent of damage to the retina and optic nerve.^[5]

A slit lamp examination is another standard test where the doctor uses a special microscope with a bright light to examine the front and back structures of your eye. This test helps identify abnormal blood vessels that may have grown on the iris or elsewhere in the eye as a complication of retinal vein occlusion. These abnormal vessels are a warning sign that the condition has become more serious.^[5]

Retinal photography creates permanent images of your retina that can be compared over time. These photographs document the appearance of blood vessels, areas of bleeding, and any other changes. Having these baseline images is valuable for monitoring whether the condition is improving, remaining stable, or getting worse.^[5]

In some cases, particularly in younger patients under age 40, doctors may recommend blood tests to look for underlying conditions that might have contributed to the blockage. These tests check for diabetes, high cholesterol, high triglyceride levels, and disorders that cause blood to clot too easily or become thicker than normal. Identifying these underlying conditions is important not only for understanding why the blockage occurred but also for preventing it from happening in the other eye.^[5]

The doctor will also check your pupil reflex response, which measures how your pupil reacts to light. In severe cases of retinal vein occlusion, the affected eye’s pupil may respond more slowly or weakly to light compared to the healthy eye. This finding can indicate significant damage to the retina or optic nerve.^[5]

Diagnostics for Clinical Trial Qualification

Clinical trials investigating new treatments for retinal vein occlusion use specific diagnostic tests to determine whether patients are eligible to participate. These studies typically require confirmation of the diagnosis through several of the standard diagnostic methods already described, but they often apply strict criteria about when the blockage occurred and how it has affected vision.

Most clinical trials require documentation through dilated eye exams and confirmation with fluorescein angiography to verify the presence and type of retinal vein occlusion. Trials may distinguish between central and branch retinal vein occlusion, and sometimes between ischemic (where blood flow is severely reduced or blocked) and non-ischemic (where some blood flow remains) types of the condition. The ischemic type is generally more severe, and fluorescein angiography is essential for making this distinction as it shows areas where the retina is not receiving adequate blood flow.^[6]

Visual acuity measurements are crucial enrollment criteria. Trials typically specify a range of vision loss that qualifies a patient for participation. For example, a study might only accept patients whose vision has deteriorated to a certain level but has not become so poor that treatment is unlikely to help. These measurements are done using standardized testing charts to ensure consistency across all participants.

Optical coherence tomography is frequently used in trial enrollment to measure the thickness of the retina, particularly in the macula. Many trials focus on treating macular edema, so they require participants to have a minimum amount of swelling documented by OCT. The test is then repeated at regular intervals throughout the trial to measure whether the experimental treatment is reducing the swelling and improving retinal thickness.

Intraocular pressure measurements are important for trial screening because some treatments, particularly steroid-based therapies, can increase eye pressure. Trials want to establish baseline pressure measurements and may exclude patients who already have uncontrolled glaucoma or very high eye pressure, as these conditions could make it unsafe to receive certain treatments.

Blood tests may be required to rule out other medical conditions that could affect trial results or put participants at risk. These might include tests for blood sugar levels in people with diabetes, blood clotting factors, cholesterol levels, and markers of inflammation or other systemic diseases.

Some trials may use additional specialized tests. For instance, electroretinography (ERG) measures electrical responses of the retina’s light-sensitive cells and can help determine whether the retina is still functioning well enough to potentially benefit from treatment. Photopic flicker ERG specifically has been shown to correlate with the severity of ischemia in retinal vein occlusion. Studies have found that certain ERG measurements can predict which patients are at highest risk of developing severe complications like abnormal blood vessel growth on the iris.^[14]

Clinical trials maintain careful monitoring throughout participation, with diagnostic tests repeated at predetermined intervals. This allows researchers to track changes in vision, retinal thickness, blood vessel growth, and other parameters over time. Patients enrolled in trials typically undergo more frequent and comprehensive testing than they would in routine clinical care, providing detailed information about how well the experimental treatment is working and whether any complications are developing.

The diagnostic requirements for clinical trial enrollment are more stringent than those for standard care because trials need to ensure that all participants have similar characteristics at the start. This standardization allows researchers to accurately measure whether an experimental treatment is effective and to compare results across different study sites and patient groups.